Journal of Molecular and Cellular Cardiology

Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair.  170:15-21. 2022

Individual variability in animal-specific hemodynamic compensation following myocardial infarction..  163:156-166. 2022

Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure.  158:72-81. 2021

Branched chain amino acids selectively promote cardiac growth at the end of the awake period.  157:31-44. 2021

Circadian influence on the microbiome improves heart failure outcomes.  149:54-72. 2020

Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction.  144:15-23. 2020

CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.  141:1-10. 2020

Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.  137:25-33. 2019

Sam68 impedes the recovery of arterial injury by augmenting inflammatory response.  137:82-92. 2019

Intracardiac administration of neutrophil protease cathepsin G activates noncanonical inflammasome pathway and promotes inflammation and pathological remodeling in non-injured heart.  134:29-39. 2019

Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.  130:65-75. 2019

HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury.  130:36-48. 2019

HDAC inhibition as a therapeutic strategy in myocardial ischemia/reperfusion injury.  129:188-192. 2019

Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.  118:70-80. 2018

The stress kinase JNK regulates gap junction Cx43 gene expression and promotes atrial fibrillation in the aged heart.  114:105-115. 2018

Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.  110:109-120. 2017

Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart.  110:80-95. 2017

Regulation of cardiac gap junctions by protein phosphatases.  107:52-57. 2017

Myocardial relaxation is accelerated by fast stretch, not reduced afterload.  103:65-73. 2017

Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.  102:83-93. 2017

A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation.  94:72-81. 2016

Computational modeling of cardiac fibroblasts and fibrosis.  93:73-83. 2016

Modifying the mechanics of healing infarcts: Is better the enemy of good?.  93:115-124. 2016

ATP sensitive K⁺ channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart.  92:116-121. 2016

Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.  92:1-9. 2016

Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging.  90:74-83. 2016

Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.  89:203-213. 2015

Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.  89:297-305. 2015

Volume overload induces autophagic degradation of procollagen in cardiac fibroblasts.  89:241-250. 2015

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.  84:24-35. 2015

NEDDylation promotes endothelial dysfunction: A role for HDAC2.  81:18-22. 2015

Cardiac fibroblast in development and wound healing.  70:47-55. 2014

GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.  72:95-103. 2014

Transmural heterogeneity of cellular level power output is reduced in human heart failure.  72:1-8. 2014

APpEaLINg therapeutic target for obesity cardiomyopathy?.  63:165-168. 2013

Cardiac immune cell remodeling after myocardial infarction.  62:142-143. 2013

Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.  62:99-107. 2013

Reduced expression of mitochondrial electron transport chain proteins from hibernating hearts relative to ischemic preconditioned hearts in the second window of protection.  60:90-96. 2013

Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.  60:72-83. 2013

Influence of dark phase restricted high fat feeding on myocardial adaptation in mice.  55:147-155. 2013

Metabolic effects of glutamine on the heart: Anaplerosis versus the hexosamine biosynthetic pathway.  55:92-100. 2013

Regulation of myocardial metabolism by the cardiomyocyte circadian clock.  55:139-146. 2013

Beta1-adrenergic receptors promote focal adhesion signaling downregulation and myocyte apoptosis in acute volume overload.  53:240-249. 2012

Normalizing the metabolic phenotype after myocardial infarction: Impact of subchronic high fat feeding.  53:125-133. 2012

Genetic loss of insulin receptors worsens cardiac efficiency in diabetes.  52:1019-1026. 2012

Regional mechanics determine collagen fiber structure in healing myocardial infarcts.  52:1083-1090. 2012

Protein O-linked β-N-acetylglucosamine: A novel effector of cardiomyocyte metabolism and function.  52:538-549. 2012

Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia.  51:236-243. 2011

Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy.  50:928-938. 2011

Cardiac cell therapy: Lessons from clinical trials.  50:258-265. 2011

Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload.  50:147-156. 2011

Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways..  49:918-930. 2010

Chronic AMD3100 antagonism of SDF-1α-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction.  49:587-597. 2010

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-ΚB andMKK7/JNK/AP-1 signaling.  49:655-663. 2010

Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca²⁺-calmodulin-dependent protein kinase II.  49:25-32. 2010

Tumor necrosis factor-α produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload.  49:70-78. 2010

Contribution of extracellular matrix to the mechanical properties of the heart.  48:490-496. 2010

Corrigendum to "Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage" [J. Mol. Cell. Cardiol. 42 (2007) 620-630] (DOI:10.1016/j.yjmcc.2006.12.004).  48:429-430. 2010

Corrigendum to "Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage" [J. Mol. Cell. Cardiol. 40 (2006) 570-579] (DOI:10.1016/j.yjmcc.2006.01.008).  48:428. 2010

Pleiotropic effects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload.  47:634-645. 2009

Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: Opposing roles of JNK1/2 and p38α MAP kinases.  45:770-778. 2008

Skeletal myoblasts and cardiac repair.  45:545-553. 2008

Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation.  45:230-239. 2008

Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCε signaling and cardioprotection.  44:1016-1022. 2008

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.  44:486-495. 2008

PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation.  44:47-58. 2008

Rapid attenuation of circadian clock gene oscillations in the rat heart following ischemia-reperfusion.  43:744-753. 2007

Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy.  43:119-129. 2007

Stretch-induced MAP kinase activation in cardiac myocytes: Differential regulation through β1-integrin and focal adhesion kinase.  43:137-147. 2007

Erratum to "Cord blood and myocardial infarction: An uncertain wedding" [J. Mol. Cell. Cardiol. 42 (2007) 727-729] (DOI:10.1016/j.yjmcc.2007.02.006).  42:1143. 2007

Regulation of cardiac substrate utilization by protein O-glycosylation.  42:s64. 2007

Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage.  42:620-630. 2007

Cord blood and myocardial infarction: An uncertain wedding.  42:727-729. 2007

Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.  42:177-185. 2007

Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases.  41:669-679. 2006

Upregulation of mitochondrial respiratory complex IV by estrogen receptor-β is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage.  41:511-521. 2006

Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.  41:340-349. 2006

A82. Bmx and c-Src mediates phosphorylation of p130Cas during cardiac hypertrophy.  40:891. 2006

Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.  40:303-312. 2006

Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage.  40:570-579. 2006

Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-β agonist: Up-regulation of cardiac heat shock factor-1 and heat shock proteins.  40:185-194. 2006

Prolonged oxidative stress inverts the cardiac force-frequency relation: Role of altered calcium handling and myofilament calcium responsiveness.  40:64-75. 2006

P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: Implications for age-associated vascular dysfunction.  39:992-995. 2005

Allopurinol and heart failure: A new use for an old drug?.  39:407-409. 2005

Post-infarction ventricular remodeling: An array of molecular events.  38:547-550. 2005

Diabetes and cardiac carbohydrate metabolism.  37:328-328. 2004

Diabetes, the hexosamine biosynthesis pathway and protein O-glycsoylation in the heart.  37:286-287. 2004

Increased carbohydrate oxidation and decreased fatty acid oxidation do not improve cardiac function after ischemia.  37:287-287. 2004

Oxidative and non-oxidative metabolic substrate fluxes in normal and ischemic rat heart.  37:287-287. 2004

Ischemic cardiac protection of high glucose/high insulin is not due to increased glucose oxidation.  36:633-633. 2004

Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.  36:567-576. 2004

Focal complex formation in adult cardiomyocytes is accompanied by the activation of β3 integrin and c-Src.  35:671-683. 2003

Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium..  35:483-493. 2003

β-Adrenergic receptor blockade modulates Bcl-XS expression and reduces apoptosis in failing myocardium.  35:483-493. 2003

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.  35:311-319. 2003

08 Altered substrate provision and cardiac function during ischemia and reperfusion.  34:a24. 2002

11 Type-2 diabetes leads to improved recovery of myocardial ischemia/reperfusion injury.  34:a25. 2002

Alterations of the circadian clock in the heart by streptozotocin-induced diabetes.  34:223-231. 2002

A comparison between NMR and GCMS 13C-isotopomer analysis in cardiac metabolism.  33:a19. 2001

Cardiac carbohydrate metabolism in hearts from normal and type-2 diabetic rats.  33:a19. 2001

The impact of type 2 diabetes on the regulation of cardiac energy metabolism and function.  33:a153. 2001

Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy.  33:69-82. 2001

Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction.  32:985-996. 2000

2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor.  31:1405-1412. 1999

Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of duchenne muscular dystrophy.  31:1857-1862. 1999

Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation.  31:1033-1045. 1999

Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.  31:1927-1936. 1999

Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism.  31:1469-1481. 1999

Nitric oxide effects on myocardial function and force-interval relations: Regulation of twitch duration.  31:2077-2085. 1999

Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations.  30:1459-1470. 1998

Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat.  29:2403-2414. 1997

Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy.  29:2665-2673. 1997

The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity.  29:2771-2778. 1997

Transforming growth factor-βs block cytokine induction of catalase and xanthine oxidase mRNA levels in cultured rat cardiac cells.  29:273-280. 1997

Autoinduction of mRNA and protein expression for transforming growth factor-βs in cultured cardiac cells.  27:805-812. 1995

Effect of temperature on Ca²⁺-dependent and mechanical modulators of relaxation in mammalian myocardium.  26:243-250. 1994

A ¹³C-NMR study of glucose oxidation in the intact functioning rat heart following diabetes-induced cardiomyopathy.  25:1203-1213. 1993

Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation.  25:949-958. 1993

Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.  23:11-22. 1991

Influence of ionic modification on electrical activity of Purkinje fibers obtained from dogs with 1-day-old myocardial infarction.  23:31-39. 1991

Vagally induced depression of impulse propagation as a cause of atrial tachycardia.  23:3-9. 1991

Alterations in dietary sodium affect isoproterenol-induced cardiac hypertrophy.  22:1135-1145. 1990

Effects of repeated low calcium perfusion on the rat heart: A grandual induction of calcium related damage.  22:131-141. 1990

The relationship between cardiac function and metabolism in acute adriamycin-treated perfused rat hearts studied by ³¹P and ¹³C NMR spectroscopy.  22:1187-1197. 1990

Hypoxia-reoxygenation induced increase in cellular Ca²⁺ in myocytes and perfused hearts: the role of mitochondria.  21:963-973. 1989

Caronary vascular function and morphology in hydralazine treated DOCA salt rats.  20:955-967. 1988

Energy dependent insulin binding, internalization and degradation in isolated cardiac myocytes from normal and diabetic rats.  18:157-168. 1986

Mechanisms of arrhythmogenes is during myocardial ischemia and reperfusion:A perspective of our current understanding.  18:43-47. 1986

Xanthine oxidase as a source of free radical damage in myocardial ischemia.  17:145-152. 1985

Isolation and characterization of β1-adrenergic receptors from adult, rat cardiac myocytes.  16:867-873. 1984

Ultrastructure of a coronary chemoreceptor of dogs and cats.  14:711-724. 1982

Effects of tetraethylammonium and 4-aminopyridine upon canine sinus node.  13:889-901. 1981

Electrical activity in canine sinus node cells during arrest produced by acetylcholine.  13:349-357. 1981

Dual dependence on both Ca²⁺ and Mg²⁺ for electrical stability in cells of canine false tendon.  11. 1979

Effect of peripheral sympathectomy on left ventricular ultrastructure in young spontaneously hypertensive rats..  10:302-305. 1978

Effect of peripheral sympathectomy on left ventricular ultrastructure in young spontaneously hypertensive rats.  10:301-305. 1978

Intramitochondrial inclusions in the myocardial cells of human hearts with coronary disease.  10. 1978

Myocardial hypertrophy and ventricular performance in the absence of hypertension in spontaneously hypertensive rats.  10:689-703. 1978

Preparation and characterization of plasma membrane of cardiac tissue.  6. 1974